WuXi Biologics and HanchorBio Enter Strategic Partnership to Advance Next-Generation Bi- and Multi-Functional Fusion Protein Pipeline

WuXi Biologics (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and ...
EurekAlert!

Missing data recovery for heterogeneous graphs with incremental multi-source data fusion

Heterogeneous graphs organize data with nodes and edges, and have been widely used in various graph-centric applications.
PharmTech

WuXi Biologics Collabs with HanchorBio on Next-Generation Fusion Protein Pipelines

HanchorBio and WuXi Biologics collaborate to develop fusion proteins using the Fc-Based Designer Biologics platform, targeting oncology and autoimmune diseases. WuXi Biologics offers end-to-end ...
EurekAlert!

Improved predictive accuracy of fusion plasma performance by data science

Theoretical and simulation estimates of turbulent transport (high-dimensional data that depend on plasma conditions such as density, temperature, and magnetic field) are used as low-fidelity data, and ...

HanchorBio and WuXi Biologics Enter Strategic Partnership to Advance Next-Generation Bi-and Multi-Functional Fusion Protein Pipeline

HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for ...